These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38160620)

  • 21. Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases.
    Dinesh DC; Tamilarasan S; Rajaram K; Bouřa E
    Curr Drug Targets; 2020; 21(2):105-124. PubMed ID: 31538891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases.
    Hajjo R; Sabbah DA; Abusara OH; Kharmah R; Bardaweel S
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses.
    Wang X; Zou P; Wu F; Lu L; Jiang S
    Front Med; 2017 Dec; 11(4):449-461. PubMed ID: 29170916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivirals and antiviral strategies.
    De Clercq E
    Nat Rev Microbiol; 2004 Sep; 2(9):704-20. PubMed ID: 15372081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repurposing drugs targeting epidemic viruses.
    Namasivayam V; Palaniappan S; Vanangamudi M
    Drug Discov Today; 2022 Jul; 27(7):1874-1894. PubMed ID: 35427764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curing a viral infection by targeting the host: the example of cyclophilin inhibitors.
    Lin K; Gallay P
    Antiviral Res; 2013 Jul; 99(1):68-77. PubMed ID: 23578729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
    Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
    J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of novel entry inhibitors targeting emerging viruses.
    Zhou Y; Simmons G
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1129-38. PubMed ID: 23199399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule RAF265 as an antiviral therapy acts against HSV-1 by regulating cytoskeleton rearrangement and cellular translation machinery.
    Li CC; Chi XJ; Wang J; Potter AL; Wang XJ; Yang CJ
    J Med Virol; 2023 Jan; 95(1):e28226. PubMed ID: 36251738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses.
    Ma Y; Frutos-Beltrán E; Kang D; Pannecouque C; De Clercq E; Menéndez-Arias L; Liu X; Zhan P
    Chem Soc Rev; 2021 Apr; 50(7):4514-4540. PubMed ID: 33595031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antivirals other than for HIV therapy.
    Harrison CJ
    Adv Pediatr; 2000; 47():335-94. PubMed ID: 10959449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
    Lobaina Y; Perera Y
    Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antivirals against animal viruses.
    Villa TG; Feijoo-Siota L; Rama JLR; Ageitos JM
    Biochem Pharmacol; 2017 Jun; 133():97-116. PubMed ID: 27697545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic optimization of host-directed therapeutic targets and preclinical validation of repositioned antiviral drugs.
    Xie D; He S; Han L; Wu L; Huang H; Tao H; Zhou P; Shi X; Bai H; Bo X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35238349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad-Spectrum Antivirals Derived from Natural Products.
    Tian WJ; Wang XJ
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
    Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Host-targeting agents in the treatment of hepatitis C: a beginning and an end?
    Baugh JM; Garcia-Rivera JA; Gallay PA
    Antiviral Res; 2013 Nov; 100(2):555-61. PubMed ID: 24091203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
    Brooks MJ; Sasadeusz JJ; Tannock GA
    Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary.
    Xu S; Ding D; Zhang X; Sun L; Kang D; Huang B; Liu X; Zhan P
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.